(PREDICT) A Multi-Center Study in Patients Undergoing Anthracycline-Based Chemotherapy to Assess the Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment

  • STATUS
    Recruiting
  • participants needed
    10
Send
Updated on 19 February 2024

Summary

Over the past 2 decades, there has been a significant increase in life span of patients with cancer so that now, there are more than 10 million cancer survivors in the U.S. [1]. There is a growing recognition that although survival has improved, many long-term side effects including cardiac complications limit quality of life and life span after cancer. Additionally, cardiac disease remains one of the most common illness affecting all patients, including those with cancer. As a result, there is a mandate from the Institute of Medicine to improve the recognition and treatment of side effects for cancer survivors [2]. The primary goal of this clinical research study is to determine if biomarker testing can help to detect early heart damage that may occur during anthracycline chemotherapy. Biomarkers are chemical markers found in the blood and can be released in response to cardiac injury. Additional secondary objectives are to define the sensitivity and specificity of echocardiography for the detection of cardiotoxicity and determine the natural history of anthracycline cardiotoxicity in patients identified as high risk via biomarkers. We will also explore genetic factors that may be associated with increased cardiotoxicity.

Details
Condition biological markers, cardiotoxins, anthracyclines
Age 1years - 99years
Clinical Study Identifier812682
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.